13F

Stock

IGC Pharma, Inc.

IGC · held by 30 managers

Reported value

$1.36M

Holders

30

+1 new · −0 exited

Holders’ est. mark

−$2.64K

Price effect on 2 books still in the name

Largest holder

$322.9K

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard1.15M$322.9KHeld
Renaissance Technologies919.6K$258.8KHeld
GEODE CAPITAL MANAGEMENT, LLC860.5K$242.2KHeld
BlackRock, Inc.703.8K$198KHeld
Citadel277.6K$78.1KHeld
State Street200.8K$56.5KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP155K$43.6KHeld
NORTHERN TRUST CORP113.4K$31.9KHeld
DEARBORN PARTNERS LLC84.4K$23.8KHeld
LAWOOD & CO75K$21.1KHeld
GOLDMAN SACHS GROUP INC65.5K$18.4KHeld
Fisher Asset Management, LLC43.4K$12.2KHeld
TRUIST FINANCIAL CORP36.7K$10.3KHeld
COMMONWEALTH EQUITY SERVICES, LLC33.3K$9.38KHeld
XTX Topco Ltd28.3K$7.97KHeld
T3 Companies, LLC20K$5.63KHeld
UBS Group AG19.9K$5.58KHeld
MORGAN STANLEY17.7K$4.98K−$2.4KCut−$2.4K
Tower Research Capital LLC (TRC)14.4K$4.05KHeld
GROUP ONE TRADING LLC7.19K$2.02KHeld
Geneos Wealth Management Inc.3K$840Held
BANK OF AMERICA CORP /DE/1.81K$508−$244Cut−$1.14K
CIBC Private Wealth Group LLC655$184Held
Caitlin John, LLC200$56Held
JONES FINANCIAL COMPANIES LLLP110$31Held
Root Financial Partners, LLC100$28Held
Farther Finance Advisors, LLC100$28Held
Hurley Capital, LLC100$28Held
DHJJ Financial Advisors, Ltd.80$23Held
Triumph Capital Management2$1New

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.